These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21344414)
21. Characterization of a site-specific PEGylated analog of exendin-4 and determination of the PEGylation site. Qian X; Dong H; Tian H; Tong Y; Guo L; Hu X; Gao X; Yao W Int J Pharm; 2013 Sep; 454(1):553-8. PubMed ID: 23827193 [TBL] [Abstract][Full Text] [Related]
22. Glucose-responsive microhydrogels based on methacrylate modified dextran/concanavalin A for insulin delivery. Yin R; Tong Z; Yang D; Nie J J Control Release; 2011 Nov; 152 Suppl 1():e163-5. PubMed ID: 22195824 [No Abstract] [Full Text] [Related]
23. Conformational and aggregation properties of a PEGylated alanine-rich polypeptide. Top A; Roberts CJ; Kiick KL Biomacromolecules; 2011 Jun; 12(6):2184-92. PubMed ID: 21553871 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels. Tuesca AD; Reiff C; Joseph JI; Lowman AM Pharm Res; 2009 Mar; 26(3):727-39. PubMed ID: 19145407 [TBL] [Abstract][Full Text] [Related]
25. Structural and biophysical characterization of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers. Dhalluin C; Ross A; Leuthold LA; Foser S; Gsell B; Müller F; Senn H Bioconjug Chem; 2005; 16(3):504-17. PubMed ID: 15898716 [TBL] [Abstract][Full Text] [Related]
26. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization. Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238 [TBL] [Abstract][Full Text] [Related]
27. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin in aqueous solutions. Taluja A; Bae YH Pharm Res; 2007 Aug; 24(8):1517-26. PubMed ID: 17385016 [TBL] [Abstract][Full Text] [Related]
29. Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b. Hermeling S; Aranha L; Damen JM; Slijper M; Schellekens H; Crommelin DJ; Jiskoot W Pharm Res; 2005 Dec; 22(12):1997-2006. PubMed ID: 16184451 [TBL] [Abstract][Full Text] [Related]
30. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models. Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239 [TBL] [Abstract][Full Text] [Related]
31. Purification of pegylated proteins. Fee CJ; Van Alstine JM Methods Biochem Anal; 2011; 54():339-62. PubMed ID: 21954785 [TBL] [Abstract][Full Text] [Related]
32. Conformational stability of lyophilized PEGylated proteins in a phase-separating system. Heller MC; Carpenter JF; Randolph TW J Pharm Sci; 1999 Jan; 88(1):58-64. PubMed ID: 9874703 [TBL] [Abstract][Full Text] [Related]
33. Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa. Plesner B; Westh P; Nielsen AD Int J Pharm; 2011 Mar; 406(1-2):62-8. PubMed ID: 21236324 [TBL] [Abstract][Full Text] [Related]
34. Characterization of singly and multiply PEGylated insulin isomers by reversed-phase ultra-performance liquid chromatography interfaced with ion mobility mass spectrometry. Gerislioglu S; Adams SR; Wesdemiotis C Anal Chim Acta; 2018 Apr; 1004():58-66. PubMed ID: 29329709 [TBL] [Abstract][Full Text] [Related]
35. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation. Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999 [TBL] [Abstract][Full Text] [Related]
36. Influence of methionine oxidation on the aggregation of recombinant human growth hormone. Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317 [TBL] [Abstract][Full Text] [Related]
37. Separation of PEGylated variants of ribonuclease A and apo-α-lactalbumin via reversed phase chromatography. Cisneros-Ruiz M; Mayolo-Deloisa K; Rito-Palomares M; Przybycien TM J Chromatogr A; 2014 Sep; 1360():209-16. PubMed ID: 25130086 [TBL] [Abstract][Full Text] [Related]
38. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958 [TBL] [Abstract][Full Text] [Related]
39. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers. Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493 [TBL] [Abstract][Full Text] [Related]
40. Capillary electrophoretic characterization of PEGylated human parathyroid hormone with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Na DH; Lee KC Anal Biochem; 2004 Aug; 331(2):322-8. PubMed ID: 15265738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]